Forum: Biotechnology Today; Characteristics of Winning Companies in the Industry

Kate Apgar kapgar at ix.netcom.com
Mon Oct 30 19:32:36 EST 1995


Tuesday, November 7,  Hyatt Rickeys, Palo Alto, CA

Light Buffet 6:00PM
Program: 6:45PM

KEYNOTE SPEAKERS:

Richard Beleson
Senior Vice President, Capital Research Co.

Peter Bick, MD
Partner, Sequoia Capital

G. Kirk Raab
Former CEO of Genentech

Approximately 250 public biotech companies are listed on
NASDAQ.  Amgen and Genentech led the pack in getting to the
$1B+ market capitilization level, but the field has been
relatively quiet until the recent surge in stock prices for
this sector.  Come hear a panel of industry experts present
a three dimensional view of the market.  Peter Bick, a 
partner at Sequoia Capital, will discuss Biotech start-up 
investing.  G. Kirk Raab, former CEO of Genentech, will 
provide a view of how to get from small to big.  Richard 
Beleson, senior vice president of Capital Research Co., 
will provide a top down perspective of where he sees 
investment opportunities in this exciting sector.

TO REGISTER:

Please call (408) 371-4460
Members/Students: $20
Non-members: $35

PRESENTED BY THE CHURCHILL CLUB - A NON-PARTISAN FORUM FOR 
SILICON VALLEY.






More information about the Bionews mailing list